Zydus Lifesciences
Bevacizumab Cancer (oncology)
Originator: Avastin · Genentech, Inc. / F. Hoffmann-La Roche Ltd
| Brand | Strength | Form |
|---|---|---|
| Bryxta (India); Bhava (Mexico) | 100 mg/4 mL and 400 mg/16 mL | — |
Ibrutinib Cancer (oncology)
Originator: Imbruvica · Pharmacyclics LLC (an AbbVie company) and Janssen Biotech, Inc. (Johnson & Johnson) - developed and commercialised jointly; US distributor of record: Pharmacyclics LLC
| Brand | Strength | Form |
|---|---|---|
| 140 mg, 280 mg, 420 mg tablets | — |
Sofosbuvir/Velpatasvir Antivirals (hepatitis C)
Originator: Epclusa · Gilead Sciences (Gilead Sciences Ireland UC for the EU)
| Brand | Strength | Form |
|---|---|---|
| Sovihep V | 400 mg + 100 mg tablet (bottle of 28) | — |
Trastuzumab Cancer (oncology)
Originator: Herceptin · Genentech, Inc. / F. Hoffmann-La Roche Ltd
| Brand | Strength | Form |
|---|---|---|
| Vivitra | 440 mg vial | — |
This page is an information resource for healthcare professionals, licensed importers and patients under medical care. It is not medical advice, not a prescription service, and not an offer to sell prescription medicines to the public.
Need a verified quotation?
Send us the molecule, strength, pack size, quantity and destination country. We reply with a batch-traceable quotation, certificates of analysis and shipping documentation.
We supply licensed pharmacies, hospitals, importers and distributors — not direct-to-consumer patients.
